Current and early life weight and associations with mortality in rheumatoid arthritis.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 28 09 2018
accepted: 14 11 2018
pubmed: 6 2 2019
medline: 9 10 2019
entrez: 6 2 2019
Statut: ppublish

Résumé

Obesity is paradoxically associated with a lower risk of mortality in chronic illnesses including rheumatoid arthritis (RA). Weight loss in patients with poor health, however, may in part explain this observation. This study evaluated the impact of weight early in life and weight loss on mortality in patients with RA. Patients with RA (age >40 years) were active participants in a prospective clinical registry with up to 17 years of follow-up. Current and age-30 body mass index (BMI) were determined from self-report of height and weight from semi-annual questionnaires. Mortality was assessed from National Death Index. Risks of obesity reported from both early in life and at enrolment in the registry were evaluated using Cox proportional hazards models. Among 12,679 participants (80% female), there were 1,520 deaths in 80,502 person-years. Obesity at enrolment (BMI >30 kg/m2) was modestly associated with greater mortality [HR: 1.34 (1.18,1.53) p=0.001]. Adjusting for disability and comorbidities hypothesised to be mediators in the causal pathway between obesity and mortality further attenuated this association [HR: 0.92 (0.80,1.06) p=0.24]. In contrast, obesity at age 30 was strongly associated with mortality [HR: 2.00 (1.65,2.42) p<0.001]. Additionally, weight loss since age-30 was a strong, dose-dependent predictor of mortality independent of enrolment BMI. The risk of obesity is substantially underestimated when epidemiologic methods do not account for long-term weight changes. Both obesity and weight loss are strongly associated with mortality risk in patients with RA.

Identifiants

pubmed: 30719967
pii: 13490

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

768-773

Subventions

Organisme : CSRD VA
ID : IK2 CX000955
Pays : United States

Auteurs

Joshua F Baker (JF)

Philadelphia VA Medical Center; Perelman School of Medicine, University of Pennsylvania; and Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. bakerjo@uphs.upenn.edu.

Andrew Stokes (A)

Department of Global Health, Boston University School of Public Health, Boston, MA, USA.

Ted R Mikuls (TR)

Medicine Service, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, USA.

Michael George (M)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Bryant R England (BR)

Medicine Service, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, USA.

Harlan Sayles (H)

Medicine Service, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha; and National Data Bank for Rheumatic Diseases, Wichita, USA.

Kaleb Michaud (K)

Medicine Service, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha; and National Data Bank for Rheumatic Diseases, Wichita, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH